logo

For the Inventor, By the Inventor

Dublin, CA, United States of America

Supergen, Inc


USPTO Granted Patents = 52

% Expired Patents = 40.4



Trademarks = 3

Forward Citations = 862

Loading Chart...
Loading Chart...

45 inventors (with patents filed for the assignee):

goldMedal Joseph Rubinfeld (23 out of 25 patents)

silverMedal Sanjeev Redkar (15 out of 26 patents)

bronzeMedal Ashok Y Gore (15 out of 15 patents)

4.  Rajashree Joshi-Hangal (8 out of 16 patents)

5.  Hariprasad Vankayalapati (6 out of 51 patents)

6.  David J Bearss (6 out of 50 patents)

7.  Pasit Phiasivongsa (5 out of 26 patents)

8.  Rajesh Shrotriya (5 out of 5 patents)

9.  Jorge F DiMartino (4 out of 5 patents)

10.  Simeon M Wrenn, Jr (4 out of 4 patents)

11.  Yong Xu (3 out of 37 patents)

12.  Xichen Zhang (3 out of 3 patents)

13.  Stephanie Gong (3 out of 3 patents)

14.  Rajashree Joshi (3 out of 3 patents)

15.  William Alexander Denny (2 out of 73 patents)


Core Competencies:
Axl Kinase Inhibitors
Quinoline Derivatives
Protein Kinase Inhibitors
DNA Methylation
Hematological Disorders
Decitabine
Camptothecin
Combination Therapy
Gene Transcription
Paclitaxel Formulation
Rheumatoid Arthritis
Therapeutic Agents

52 patents:

1. 7998966 - Axl kinase inhibitors (2011-08-16),
2. 7939546 - Quinoline derivatives for modulating DNA methylation (2011-05-10),
3. 7820684 - Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same (2010-10-26),
4. 7790746 - Quinoline derivatives for modulating DNA methylation (2010-09-07),
5. 7750007 - Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors (2010-07-06),
6. 7700567 - Oligonucleotide analogues incorporating 5-aza-cytosine therein (2010-04-20),
7. 7326712 - Substituted tricyclic compounds as protein kinase inhibitors (2008-02-05),
8. 7276228 - Methods for treating hematological disorders through inhibition of DNA methylation and histone deacetylase (2007-10-02),
9. 7250416 - Azacytosine analogs and derivatives (2007-07-31),
10. 7144873 - Kit for delivering decitabine in vivo (2006-12-05),
11. 7135464 - Method of administering decitabine (2006-11-14),
12. 7071202 - Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor (2006-07-04),
13. 7060290 - Phosphocholine linked prodrug derivatives (2006-06-13),
14. 7049322 - Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor (2006-05-23),
15. 7037900 - Composition and method for treating graft-versus-host disease (2006-05-02),
Supergen, Inc is a leading technology company specializing in innovative solutions for the renewable energy sector. With a focus on research, development, and implementation, we strive to create sustainable and efficient energy solutions. Our team of experts is dedicated to delivering cutting-edge technology and superior customer service. Visit our website to learn more about our products and services.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

52 Patents

#6 in Dublin, CA

#1,586 in California

#6,754 in US

#13,523 in the World

Dublin, CA (US)
Dublin, CA, United States of America

Supergen, Inc

Forward Citations = 862

45 inventors:

goldMedal Joseph Rubinfeld (23 out of 25 patents)

silverMedal Sanjeev Redkar (15 out of 26 patents)

bronzeMedal Ashok Y Gore (15 out of 15 patents)

4.  Rajashree Joshi-Hangal (8 out of 16 patents)

5.  Hariprasad Vankayalapati (6 out of 51 patents)

Please report any incorrect information to [email protected]
Loading…